Lightcalls.com
 

The Devil's claw plant (Harpagophyt...

The Devil's claw plant (Harpagophytum pricumbens) was given this vivid name in hint to the claw-shaped growths -- total with imposing thorns adorned with several finger-like vegetations -- which wrap around and defend the plant's seeds. These claws are extremely tough, requiring pliers to bend the fingers make open and release the seeds within.

Devil's claw plants are native to southwest Africa, namely the Kalahari wilderness Namibian Steppes, and the island of Madagascar. In adapting to these harsh, craving drink environments, Devil's claw takes advantage of the short rainy season on storing up water for the ease of the year in tubers, which act as subterranean reservoirs for the plant. It is these subterranean tubers that have been used medicinally from indigenous African tribes, primarily for arthritic conditions, on the contrary also for wound healing and skin irritations.

Europeans traveling to Africa heard the tales of the health-enhancing properties of Devil's claw, and brought samples back to Germany and other European countries to impose Devil's claw root to the trial The clinical research using Devil's claw stem for arthritic conditions proved favorable, the first reflection having appeared in 1958. Devil's claw quickly gained recognition from first to last Europe for alleviating arthritis symptoms, particularly for reducing pain and inflammation.



Studies have also been undertaken to understand the active ingredients in Devil's claw. clevers believe that the tubers of Devil's claw contain three active ingredients, all of which are classified in the iridoid glycoside family. These are: harpagoside, harpagide, and procumbide, and they are reput to account for the inflammation-fighting and pain-relieving efficiencys Other identified compounds include: beta-sitosterol, stigmasterol, fatty acids, triterpenes, and flavonoids. near scientists have discovered that the secondary tubers of Devil's claw contain as plenteous as twice the active ingredients as the primary tubers.

Continuing the research tradition

Although Devil's claw is commonly more popular in Europe, the U is not without Devil's claw [i]connoisseur[/i]s Dr. Wallace W. Brawley, who is associated with PISGAH Biomedical Research Center Inc. in Asheville, NC explained that he became interested in Devil's claw for arthritis after reading the favorable European studies.

Since then, he embarked relating to an informal research study of arthritis sufferer "Keeping in mind that this research has not been double-blinded, moreover is of an observational nature, we have nonetheless seen remarkable results" Brawley said in an interview with BN

A total of 38 the community with arthritis have been tracked at Brawley, to date. Diagnostic proofs such as X rays, are given before and after the use of Devil's claw postscripts while any changes in symptoms are tracked for the duration of the supplementation period. According to Brawley, more than 90 percent of these patients report marked improvement in pain and inflammation. And Brawley, although not part of the research group, shared that he personally has experienced benefits from Devil's claw, after an injury that damaged the joints of his hand.

Brawley rehearseed another anecdote of a man with arthritis who experienced as it is severe pain in his shoulder that he couldn't raise his arm. At Brawley's suggestion, he began treatment with Devil's claw. After several weeks, he passed at Brawley's office, stating that he just wanted to say "Hi," whereupon he raised his arm and waved without any discomfort.

A 23-week course of treatment is commended by Brawley, but after just three to four weeks, improvements are frequently seen, even during X-ray assessment. And, smooth a few days after commencing treatment, many the bulk of mankind note a lessening of arthritis symptoms.

speculation to be better for osteoarthritis than for rheumatoid arthritis, this herb can be synergistically used in quota with (or in succession with): angelica, St John's wort, bogbean (Menyanthes trifoliata), Boswellia serrata, and Ashwagandha.

Devil's claw has no known toxicity. The simply cautionary is that it can advance stomach acid, and should therefore not be used through anyone with an ulcer (unles supervised from a naturopathic doctor or other licensed health practitioner). onward the other hand, Devil's claw's stimulation of stomach acid can be used to improve digestion, which is however another benefit of this African herb.

REFERENCE

Lanhers, MC et al. "Anti-inflammatory and analgesic tenors of an aqueous extract of Harpagophytum procumbens," Planta Medica 58(2): 117-123 1992

COPYRIGHT 1997 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.